Mersana Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
MRSN on Nasdaq
Industry
Pharmaceutical Preparations
Location
840 Memorial Drive, Cambridge, MA

Insiders trading volume in the past year

Mersana Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Nextech Crossover I Scsp 10%+ Owner $22.9M Dec 20, 2024
EcoR1 Capital, LLC 10%+ Owner $21.5M Dec 19, 2024
David Mott Director $1.62M Jun 11, 2024
Timothy B. Lowinger SVP, Chief Sci.&Tech. Officer $316K -$35.2K -10% Jan 15, 2025
Martin H. Huber Jr. President, CEO, Director $296K -$91.4K -23.6% Jan 15, 2025
Brian DeSchuytner Svp, Coo & Cfo $265K -$36K -12% Jan 15, 2025
Mohan Bala SVP, Chief Development Officer $237K -$36.3K -13.3% Jan 15, 2025
Alejandra Carvajal SVP, Chief Legal Officer $212K -$32.9K -13.4% Jan 15, 2025
Tushar Misra SVP, Chief Manuf. Officer $162K Jan 13, 2024
Arvin Yang SVP, Chief Medical Officer $141K Jan 13, 2023
Anna Protopapas Director $139K -$16.5K -10.6% Jan 15, 2025
Willard H. Dere Director $106K Jun 11, 2024
Michael J. Kaufman Chief Manufacturing Officer $88.4K Jul 15, 2021
Ashish Mandelia VP, Chief Accounting Officer $88.2K -$20.2K -18.6% Jan 15, 2025
Andrew Hack Director Jun 11, 2024
Lawrence M. Alleva Director Jan 2, 2025
Kristen Hege Director Jun 11, 2024
Allene M. Diaz Director Jun 11, 2024

Recent Insider Transactions by Companies or Individuals for Mersana Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.